FDA inspection
Triumph Pharmaceuticals Inc.: FDA inspection ending Jan 19, 2023
FDA inspection 1196117 · Voluntary Action Indicated (VAI) · Saint Louis, MO
Key facts
| Inspection ID | 1196117 |
|---|---|
| Firm | Triumph Pharmaceuticals Inc. |
| FEI number | 3014539253 |
| Address | 12312 Olive Blvd Ste 25 |
| City | Saint Louis |
| State | MO |
| ZIP | 63141 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jan 19, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data